Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SAKAR

Sakar Healthcare Ltd

HealthcarePharmaceuticals & Biotechnology₹2247 cr market cap
₹980.75 ▼ -2.87% today As of 19 Nov 2026
52-week low ₹361.9052-week high ₹1188.40

-15.0% from the 52-week high · +179.0% above the low

Sakar Healthcare Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2016-10-14. The firm is engaged in providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules, vials and lyophilized injections, oral solid dosages, and research and development of these products. The Company’s products include Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin - Oral Solid and Lyophilised Injections (In Vials). The firm operates as a contract development and manufacturing organization (CDMO). The firm has approximately 321 product registrations in various countries. The manufacturing unit has been accredited by regulatory authorities of 14 countries, which includes Uganda, Kenya, Yemen, Ethiopia, Congo, Zimbabwe, Nigeria, Malawi, Philippines, Peru, Vietnam, Cote D’Ivoire.

The short version. Sakar Healthcare Ltd reported revenue of ₹87 crore for Sep 2026, up 50.0% from a year earlier. Net profit was ₹11 crore (up 120.0% year on year). Promoter holding was 51.7% in Sep 2026, down 1.88 points over 8 quarters.

1 · The price

How has the stock traded?

Sakar Healthcare Ltd trades 15.0% below its 52-week high and 179.0% above its 52-week low.

Change over period: —

1M+9.4%
3M+15.9%
6M+24.8%
1Y+150.5%

2 · The business

Is it growing?

Sales, year on year+50.0%

Sep 2026 revenue of ₹87 cr.

Profit, year on year+120.0%

Sep 2026 net profit of ₹11 cr.

Net margin12.9%

5.0 pts higher than a year earlier.

3-year growth33.7% profit

Revenue compounded at 22.6% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue8773717058535043
Net profit111011105565
Net margin %12.914.115.514.67.98.911.510.4
EPS (₹)5.084.624.954.612.042.12.622.06

Annual

FY2026FY2025FY2024FY2023FY2022FY2021
Revenue25217815313312895
Net profit301812131511
Net margin %12.19.97.69.611.711.3
EPS (₹)13.77.975.376.78.736.84

3 · The quality

How well does it turn capital into profit?

.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %—6.14.57.4
Return on capital %—8.57.18.1
EBITDA margin %28.028.526.527.4
Net margin %12.09.87.59.2

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR22.6%21.5%
Profit CAGR33.7%23.3%
Interest cover6.1x
P/E ratio52.2

4 · The owners

Who holds it, and are they adding?

Promoter holding51.7%

Down 1.88 pts over 8 quarters.

Foreign institutions12.34%

Down 1.24 pts over 8 quarters.

Domestic institutions11.92%

Up 1.04 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter53.5853.5852.8652.8652.8652.8652.5251.7-1.88
FII13.5813.6113.4113.3113.0512.9412.1312.34-1.24
DII10.8810.9711.2511.4311.3611.3211.3711.92+1.04
Public21.9621.8522.4822.4122.7322.8723.9824.04+2.08

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for Sakar Healthcare Ltd are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about Sakar Healthcare Ltd

What is the Sakar Healthcare Ltd share price?

Sakar Healthcare Ltd (SAKAR) last closed at ₹980.75, down 2.87% on the day. Its 52-week range is ₹361.90 to ₹1,188.40.

What is the market cap of Sakar Healthcare Ltd?

Sakar Healthcare Ltd has a market capitalisation of about ₹2,247 crore. Its price-to-earnings ratio is 52.2.

How are Sakar Healthcare Ltd's latest results?

Sakar Healthcare Ltd reported revenue of ₹87 crore for Sep 2026, up 50.0% from a year earlier. Net profit was ₹11 crore (up 120.0% year on year). Promoter holding was 51.7% in Sep 2026, down 1.88 points over 8 quarters.

Who owns Sakar Healthcare Ltd?

As of Sep 2026, shareholding was: Promoter 51.7%, FII 12.34%, DII 11.92%, Public 24.04%.

How many mutual funds hold Sakar Healthcare Ltd?

0 mutual fund schemes held Sakar Healthcare Ltd in October 2026. That compares with 0 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.